FDA Plans to Warn J&J Covid-19 Vaccine Raises Risk of Rare Neurological Condition
U.S. health regulators are expected to warn that the Johnson & Johnson Covid-19 vaccine is linked to a very small incidence of cases of a rare neurological disorder associated with other shots.
Dow Jones & Company, Inc. 4300 U.S. Route 1 North Monmouth Junction, NJ 08852 You are currently subscribed as newsletter@newslettercollector.com. For further assistance, please contact Customer Service at support@wsj.com or 1-800-JOURNAL.
Copyright 2021 Dow Jones & Company, Inc. | All Rights Reserved.